Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

about

Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease.Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/IkappaB kinase/nuclear factor kappaB pathway.

P2860

Q37756172-82FA515E-D292-463E-B6FF-FB3EC884A48D Q41416602-0D912FAD-5B42-42C9-B398-21EDD9391FD6

P2860

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q35911103

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

@ast

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

@en

type

Item

label

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

@ast

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

@en

prefLabel

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

@ast

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

@en

P1476

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

@en

P2093

Andrew D Cook

http://www.w3.org/2001/XMLSchema#string

Kumar Visvanathan

http://www.w3.org/2001/XMLSchema#string

P2860

Microarray analysis of gene expression in lupus

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease

T-cell co-stimulation through B7RP-1 and ICOS

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

Mass spectrometry-based proteomics

Natalizumab for active Crohn's disease

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Macrophage-derived IL-18 targeting for the treatment of Crohn's disease

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

P304

375-390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.8.5.375

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15469389

http://www.w3.org/2001/XMLSchema#string

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

about

P2860

P2860

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698